Publication | Closed Access

Identification of N-phenyl-N′-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4

Medicinal ChemistryBiochemistryGp120 BindingMedicineNatural SciencesHuman RetrovirusHiv-1 Entry InhibitorsNew ClassPharmacotherapyAntiviral DrugHivPharmacologyAntiviral CompoundDrug Discovery